G.R.Bioure Surgical System Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 05-12-2024
- Paid Up Capital ₹ 2.22 Cr
as on 05-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.44 Cr
as on 05-12-2024
- Satisfied Charges ₹ 7.20 M
as on 05-12-2024
- Revenue 74.22%
(FY 2023)
- Profit 102.46%
(FY 2023)
- Ebitda 26.10%
(FY 2023)
- Net Worth 25.08%
(FY 2023)
- Total Assets 15.92%
(FY 2023)
About G.R.Bioure Surgical System
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.22 Cr.
The company currently has active open charges totaling ₹6.44 Cr. The company has closed loans amounting to ₹7.20 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Goyal and Paavan Rastogi serve as directors at the Company.
- CIN/LLPIN
U33110DL2011PTC213220
- Company No.
213220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at G.R.Bioure Surgical System?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Goyal  | Director | 01-Feb-2011 | Current |
| Paavan Rastogi | Director | 01-Feb-2011 | Current |
Financial Performance of G.R.Bioure Surgical System.
G.R.Bioure Surgical System Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.22% increase. The company also saw a substantial improvement in profitability, with a 102.46% increase in profit. The company's net worth Soared by an impressive increase of 25.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G.R.Bioure Surgical System?
In 2023, G.R.Bioure Surgical System had a public holding of 64.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jun 2024 | ₹2.77 Cr | Open |
Hdfc Bank Limited Creation Date: 31 May 2024 | ₹2.17 M | Open |
Others Creation Date: 29 Feb 2024 | ₹5.65 M | Open |
How Many Employees Work at G.R.Bioure Surgical System?
Unlock and access historical data on people associated with G.R.Bioure Surgical System, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G.R.Bioure Surgical System, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G.R.Bioure Surgical System's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
